| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $86.1M | +4.7% |
| SG&A Expense | $18.8M | -23.8% |
| Operating Income | -$105.0M | +1.9% |
| Income Tax | $2K | +100.0% |
| Net Income | -$96.7M | +7.8% |
| EPS (Basic) | -$2.14 | +18.3% |
| EPS (Diluted) | -$2.14 | +18.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.5M | +189.2% |
| Short-term Investments | $193.3M | +6.9% |
| Current Assets | $266.5M | +27.6% |
| Total Assets | $276.9M | +28.4% |
| Current Liabilities | $21.6M | +30.6% |
| Total Liabilities | $23.1M | +27.4% |
| Stockholders' Equity | $253.9M | +28.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$83.7M | -2.0% |
| Capital Expenditures | $363K | +0.0% |
| Investing Cash Flow | -$4.9M | -105.3% |
| Financing Cash Flow | $133.4M | — |
| Free Cash Flow | -$84.1M | -2.0% |